GSK links with Fimbrion to develop UTI drug
GlaxoSmithKline has formed a partnership with US biotech Fimbrion Therapeutics to develop a first-in-class small molecule drug for the treatment and prevention of urinary tract infections (UTIs).
Read More
Tag: mannosides
- FDA approves new high dose Spinraza regimen for SMA
- Viridian reports positive results from elegrobart phase 3 trial
- Cure Parkinson’s convenes expert panel to assess £2 million combination therapy funding call
- Kygevvi approved in Europe as first treatment for TK2d
- Tozorakimab shows significant benefit in two major COPD trials
